Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

BMX-001 acts as a selective chemoradioprotector in rectal cancer.

Redox biochemistry and chemistry·2026

Same author

Wild-Type p53 Protein Enhances APR-246-Induced Cytotoxicity in Acute Myeloid Leukemia and Normal Hematopoietic Stem/Progenitor Cells.

International journal of molecular sciences·2026

Same author

The Use of Deep Learning in RNA Therapeutic Development.

ACS nano·2026

Same author

Haematococcus pluvialis microzooid and palmella cells display distinct metabolic responses to excess manganese.

Plant physiology and biochemistry : PPB·2026

Same author

Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Chromosomal instability induced by CRISPR/Cas9: implications for pancreatic cancer therapy.

The Journal of clinical investigation·2026

Same journal

Dual-Function Halide Exchange Strategy for Simultaneous Sn<sup>4+</sup> Elimination and Stability Enhancement in Pb-Sn Mixed Perovskite Solar Cells.

ACS nano·2026

Same journal

Vertically Stacked Indium Gallium Zinc Oxide-Based Three-Dimensional Integrated Circuits.

ACS nano·2026

Same journal

Tunable Nanoparticle Thin-Film Reveals Distance Dependence of Auger-Mediated Radiation Enhancement in Diffuse Midline Glioma.

ACS nano·2026

Same journal

G-Quadruplex Network Engineering in Ionogels: Realizing Robust Biosensing Interfaces for Plant Electrophysiology.

ACS nano·2026

Same journal

Announcing the 2026 <i>ACS Nano</i> Lectureship and <i>ACS Nano</i> Impact Award Laureates.

ACS nano·2026

Same journal

Ultrafast Self-Assembly of Zeolitic Imidazolate Framework-8 Enables Antibody Orientation for Ultrasensitive Lateral Flow Immunoassays.

ACS nano·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Nanosponge Tunability in Size and Crosslinking Density

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery.

Zilu Zhang¹, Yan Xiang¹, Joe Laforet¹

¹Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708, United States.

|September 11, 2025

Summary

This summary is machine-generated.

Artificial intelligence (AI) accelerates nanoparticle formulation by optimizing materials and ratios simultaneously. This AI-driven approach enhances drug delivery development and improves formulation success rates.

Keywords:

drug delivery lab automation machine learning nanoparticle tunable composition

More Related Videos

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Related Experiment Videos

Last Updated: Jun 15, 2026

Nanosponge Tunability in Size and Crosslinking Density

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Area of Science:

Biotechnology and Bionanotechnology
Materials Science
Computational Chemistry

Background:

Current nanoparticle development often optimizes material selection or component ratios independently.
Simultaneous optimization of both material selection and component ratios is crucial for efficient nanoparticle formulation.
Existing methods lack a systematic approach to explore the complex nanoparticle formulation space.

Purpose of the Study:

To develop an integrated platform combining automated experimentation and machine learning for simultaneous optimization of nanoparticle formulation.
To create a novel hybrid kernel machine learning model for enhanced prediction of formulation outcomes.
To demonstrate the platform's efficacy in formulating challenging drug molecules and optimizing existing formulations.

Main Methods:

Integration of an automated liquid handling platform with machine learning algorithms.
Generation of a comprehensive dataset of 1275 distinct nanoparticle formulations.
Development of a bespoke hybrid kernel machine coupling molecular feature learning and compositional inference.
Utilizing a support vector machine (SVM) with the novel kernel for prediction and guidance.

Main Results:

Achieved a 42.9% increase in successful nanoparticle formation through composition optimization.
The hybrid kernel significantly improved prediction performance across kernel-based algorithms, with SVM showing superior results.
Successfully formulated venetoclax, improving in vitro efficacy against leukemia cells.
Reduced excipient usage by 75% in a trametinib formulation while maintaining efficacy and pharmacokinetic properties.

Conclusions:

The study establishes a generalizable AI-driven framework for accelerating nanoparticle composition optimization.
The integrated platform enables simultaneous optimization of materials and ratios, overcoming limitations of traditional methods.
This approach holds significant potential for advancing nanoparticle-based drug delivery systems.